Multicenter analytical performance evaluation of a fully automated anti-Mullerian hormone assay and reference interval determination


Anckaert E., Oktem M., Thies A., Cohen-Bacrie M., Daan N. M. P., Schiettecatte J., ...Daha Fazla

CLINICAL BIOCHEMISTRY, cilt.49, sa.3, ss.260-267, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 49 Sayı: 3
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.clinbiochem.2015.10.008
  • Dergi Adı: CLINICAL BIOCHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.260-267
  • Anahtar Kelimeler: Immunoassay, Anti-Mullerian hormone (AMH), Electrochemiluminescence immunoassay (ECLIA), Polycystic ovary syndrome (PCOS), Elecsys (R) AMH, POLYCYSTIC-OVARY-SYNDROME, MLLERIAN HORMONE, SYNDROME PCOS, MOUSE OVARY, IN-VITRO, GEN II, DEFINITION, WOMEN, REPRODUCIBILITY, IMMUNOASSAY
  • Gazi Üniversitesi Adresli: Hayır

Özet

Objectives: Anti-Mullerian hormone (AMH) is an established biomarker for assessing ovarian reserve and predicting response to controlled ovarian stimulation. Its routine clinical use is hampered by the variability and low-throughput of available enzyme-linked immunosorbent assays (ELISA). The presented study examined if a fully automated AMH electrochemiluminescence assay (ECLIA; Elecsys (R) AMH assay, Roche Diagnostics) was suitable for measuring AMH levels in healthy women and in those diagnosed with polycystic ovary syndrome (PCOS).